NEW YORK, Nov. 17, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) (Frankfurt:HUQ) is pleased to announce the immediate appointment of Mr. Rob Gillingham to its Board of Directors.
Mr. Gillingham is a Canadian Chartered Account who completed articles with Coopers & Lybrand. From 1993 to 2003 Mr. Gillingham served as the president of Java Group Inc. a publicly listed company involved in the retail food services industry with strong ties in Germany specializing in the marketing of brewed and bulk gourmet coffees. He has also provided financial consulting and corporate structure services to both private and public companies.
Reid Li, Amersin's Chief Executive Officer said, "We are very proud to have Mr. Gillingham join our team. He brings a tremendous depth of experience in financing and corporate development, particularly in the natural resources sectors including forestry, mining, oil and gas. His professional qualifications and extensive business development experience will be invaluable to the management team and to the future development of our Company."
"Safe Harbor" Statement: This news release contains certain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from the forward-looking statements contained herein. Detailed information about many risk factors are set forth in Amersin's periodic filings with the Securities and Exchange Commission including, but not limited to, those risks and uncertainties listed in the sections entitled "Cautionary Note Regarding Forward-Looking Statements" and "Management's Discussion and Analysis" in Amersin's most recent Quarterly Report on Form 10-QSB. All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval system (EDGAR) at http://www.sec.gov or the Amersin web site at http://www.amersin.com. Amersin is under no obligation, and expressly disclaims any obligation, to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
The Amersin Life Sciences Corp. logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=1616